Aeterna Zentaris (AEZS) News Today → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free AEZS Stock Alerts C$11.06 -0.03 (-0.27%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 3, 2024 | americanbankingnews.comAeterna Zentaris (TSE:AEZS) Stock Price Down 2.1%May 1, 2024 | theglobeandmail.comAEterna Zentaris: Top 10 Undervalued Healthcare Sector Stocks on TSX (AEZS)March 31, 2024 | theglobeandmail.comAEterna Zentaris: Top 25 Undervalued Toronto Stock Exchange Stocks (AEZS)March 28, 2024 | markets.businessinsider.comCourt Approves Ceapro-Aeterna Merger - Quick FactsMarch 28, 2024 | finance.yahoo.comCeapro Receives Final Court Approval for Merger with Aeterna ZentarisFebruary 21, 2024 | benzinga.comAEterna Zentaris Stock (NASDAQ:AEZS) Dividends: History, Yield and DatesFebruary 15, 2024 | msn.comAeterna Zentaris files to sell 2.53M warrantsFebruary 15, 2024 | finance.yahoo.comAeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproJanuary 22, 2024 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc flat on Monday (AEZS)December 14, 2023 | tmcnet.comAEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to ShareholdersDecember 14, 2023 | marketwatch.comAeterna Zentaris, Ceapro to CombineDecember 14, 2023 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - AEZSDecember 14, 2023 | markets.businessinsider.comAeterna Zentaris Enters Into Merger Agreement With CeaproDecember 14, 2023 | msn.comAeterna Zentaris and Ceapro to merge in all-stock dealOctober 20, 2023 | theglobeandmail.comAEterna Zentaris: Top 10 Undervalued Growth Stocks on TSX (AEZS)August 9, 2023 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Reports Second Quarter 2023 Financial ResultsAugust 9, 2023 | finance.yahoo.comAeterna Zentaris Reports Second Quarter 2023 Financial ResultsJuly 14, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Aeterna Zentaris (AEZS) and Alnylam Pharma (ALNY)July 5, 2023 | finance.yahoo.comAeterna Zentaris to Participate in the Virtual Investor Summer Spotlight SeriesJune 14, 2023 | finance.yahoo.comAeterna Zentaris Announces Results of Virtual 2023 Meeting of ShareholdersMay 25, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc down on Thursday (AEZS)May 24, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc up on Tuesday (AEZS)May 5, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc up on Friday (AEZS)April 21, 2023 | thestreet.comSpeculative Money Propels Biotechs La Jolla Pharma, Aeterna ZentarisApril 10, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Timber Pharmaceuticals (TMBR), Aeterna Zentaris (AEZS) and Cabaletta Bio (CABA)March 28, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Aeterna Zentaris (AEZS), Delcath Systems (DCTH) and GlaxoSmithKline (GSK)March 23, 2023 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 18, 2023 | stockhouse.comPharmanovia to Market GHRYVELIN(TM) (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)February 17, 2023 | ca.finance.yahoo.comAeterna Zentaris Inc. (AEZS.TO)January 11, 2023 | thestreet.comAEterna Zentaris Stock Gaps Down On Today's Open (AEZS)January 5, 2023 | benzinga.comAEterna Zentaris Stock (NASDAQ:AEZS), Quotes and News SummaryNovember 3, 2022 | msn.comAEterna Zentaris: Q3 Earnings InsightsSeptember 25, 2022 | finance.yahoo.comAeterna Zentaris Inc. (AEZS)September 14, 2022 | reuters.comAeterna Zentaris IncAugust 30, 2022 | stockhouse.comAeterna Zentaris Set to Regain Full Rights to Macrilen(TM) (Macimorelin) in U.S. and Canada from Novo NordiskAugust 2, 2022 | theglobeandmail.comAeterna Zentaris Inc stock eased on Friday.July 18, 2022 | finanznachrichten.deAeterna Zentaris Inc: Aeterna Zentaris Announces Shareholder Approval of Share ConsolidationJuly 15, 2022 | finance.yahoo.comAeterna Zentaris Announces Shareholder Approval of Share ConsolidationJuly 6, 2022 | finance.yahoo.comAeterna Zentaris Announces Further Adjournment of Shareholder MeetingJune 21, 2022 | finance.yahoo.comAeterna Zentaris Announces Results of Annual Meeting of ShareholdersJune 13, 2022 | finance.yahoo.comAeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals ProgramJune 3, 2022 | finance.yahoo.comHere's Why We're Watching Aeterna Zentaris' (TSE:AEZS) Cash Burn SituationMay 25, 2022 | finance.yahoo.comAeterna Zentaris’ Licensing Partner, Consilient Health Announces European Launch of Ghryvelin™ (macimorelin) for Diagnosing Adult Growth Hormone DeficiencyMay 18, 2022 | finance.yahoo.comAeterna Zentaris to Present at the H.C. Wainwright Global Investment ConferenceMay 16, 2022 | finance.yahoo.comAeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share ConsolidationApril 28, 2022 | finance.yahoo.comGranite Point Mortgage Trust Inc. Announces $590 million Refinancing of Legacy Funding Vehicles, Incremental $50 million Repayment of Term Loan Borrowings and Preliminary Financial Results for First Quarter 2022April 12, 2022 | finance.yahoo.comAeterna Zentaris to Participate at the Virtual Investor 2022 CEO SpotlightMarch 21, 2022 | finance.yahoo.comAeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyMarch 2, 2022 | seekingalpha.comAeterna Zentaris to get US patent for potential hormone disorder therapy AEZS-150March 2, 2022 | finance.yahoo.comAeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Free report reveals “two-baggers” for 2024 (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable. Download your free report today! AEZS Media Mentions By Week AEZS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEZS News Sentiment▼0.000.58▲Average Medical News Sentiment AEZS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEZS Articles This Week▼00▲AEZS Articles Average Week Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ProMIS Neurosciences News Today Small Pharma News Today Microbix Biosystems News Today IBEX Technologies News Today Theratechnologies News Today Aptose Biosciences News Today Covalon Technologies News Today Ceapro News Today Sirona Biochem News Today Kane Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:AEZS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon to Transform U.S. Economy? Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
